Original ArticleThe Carotid Revascularization Endarterectomy versus Stenting Trial: Credentialing of Interventionalists and Final Results of Lead-in Phase
Section snippets
Credentialing of CAS Operators in the CREST Lead-in Study
The first step in the credentialing process was selecting interventionalists for the lead-in phase of CREST. To document their experience and technical skills, candidates had to submit records of their CAS cases, including admission notes, indications for CAS, procedure reports, and discharge summaries, to a multidisciplinary Interventional Management Committee (IMC). The number of cases before the lead-in reflected cases over the preceding months to several years. A physician-reviewer on the
Credentialing Process
CREST sent invitations to 140 candidate sites, requesting data from potential interventionalists and surgeons.12 During 137 teleconferences, the IMC reviewed 10,164 CAS cases from 427 applicants (Fig 1). Of the 427 stent operators who applied for the trial, 224 (52.4%) were ultimately approved for the randomization phase.
The IMC did not approve 116 applicants for participation in the lead-in study. The primary reason that approval was not granted was insufficient experience; applicants either
Discussion
This article describes the most extensive credentialing process for carotid interventionalists yet reported. The process involved assessment of the clinical and technical acceptability to enter a credentialing registry by a multidisciplinary IMC, rigorous per-protocol assessment of outcomes in a lead-in registry, and approval for CREST by the IMC, largely on the basis of data from the registry.
The CREST lead-in phase is the largest federally funded study of its type, with 414 symptomatic
Conclusions
Large multicenter randomized trials that compare technical procedures ideally include rigorous training and credentialing protocols. Careful selection, training, and lead-in registry analysis of operators prerandomization are expected to ensure that the results of a randomized trial are applicable to the quality standards expected in the medical community. In the CREST lead-in study, which included both conventional-risk and higher-risk symptomatic and asymptomatic patients, outcomes achieved
References (22)
- et al.
Carotid artery stenting is associated with increased complications in octogenarians: 30-day stroke and death rates in the CREST lead-in phase
J Vasc Surg
(2004) - et al.
Surgical results: a justification of the surgeon selection process for the ACAS trial
J Vasc Surg
(1996) - et al.
Protected carotid stenting in high-surgical-risk patients: the ARCHeR results
J Vasc Surg
(2006) - et al.
Clinical and angiographic risk factors for stroke and death within 30 days after carotid endarterectomy and stent-protected angioplasty: a subanalysis of the SPACE study
Lancet Neurol
(2008) - et al.
Treatment of asymptomatic carotid disease with stenting: pro
Semin Vasc Surg
(2008) Methods, patient characteristics, and progress
Stroke
(1991)Endarterectomy for asymptomatic carotid artery stenosis
JAMA
(1995)- et al.
Selection process for surgeons in the Asymptomatic Carotid Atherosclerosis Study
Stroke
(1991) - et al.
The CAPTURE registry: results of carotid stenting with embolic protection in the post-approval setting
Catheter Cardiovasc Interv
(2007) - et al.
Does sex matter? Thirty-day stroke and death rates after carotid artery stenting in women versus men: results from the Carotid Revascularization Endarterectomy versus Stenting Trial (CREST) lead-in phase
Stroke
(2009)
Further comments on the measurement of carotid stenosis from angiograms
Stroke
Cited by (0)
Supported by National Institutes of Health, National Institute of Neurological Disorders of Stroke Grant RO1-NS38384. Industry support was provided by Abbott Vascular Solutions (formerly Guidant Endovascular Solutions).
The authors report no conflicts of interest.
Clinical trials registration identifier: NCT00004732.
- ∗∗∗
Deceased.